A Study of Modified mRNA Vaccines in Healthy Adults
Conditions:   SARS-CoV-2;   Seasonal Influenza;   Respiratory Syncytial Virus;   Cytomegalovirus Interventions:   Biological: mRNA-1273;   Biological: mRNA-1010;   Biological: mRNA-1345;   Biological: FLUAD®;   Biological: mRNA-1647 Sponsor:   ModernaTX, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2022 Category: Research Source Type: clinical trials

Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis > > GVHD PROPHYLAXIS ERA
Condition:   CMV Infection Intervention:   Sponsors:   Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud;   Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2022 Category: Research Source Type: clinical trials